Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) - Investigating Matching, Biomarkers and Outcomes.

NCT07263490 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Hvidovre as lead sponsor.

NCT NCT07263490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07263490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) - Investigating Matching, Biomarkers and Outcomes.
Lead sponsor
Copenhagen University Hospital, Hvidovre
Phase
Observational
Overall status
Recruiting
Start date
October 21, 2024
Completion date
June 1, 2028
Enrollment
462 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

art, gestational diabetes, hypertensive disorders of pregnancy, intrauterine growth restriction (iugr), neonatal morbidity, neonatal mortality, oocyte donation, placental abruption, post-partum hemorrhage (pph), pre-eclampsia, pre-eclampsia or eclampsia with pre-existing hypertension, pre-eclampsia, severe, pre-eclampsia; complicating pregnancy, pre-eclampsia; mild, preterm labor